March 13 (Reuters) - Eli Lilly ( LLY ) said on Wednesday
it has brought on Amazon.com's ( AMZN ) pharmacy unit to deliver
drug prescriptions sent to its direct-to-consumer service,
LillyDirect.
Lilly launched the platform in January to enable patients to
obtain their migraine, diabetes and obesity drugs, including the
popular weight-loss medicine Zepbound, directly from the company
via delivery from online pharmacy Truepill.
The drugmaker said prescriptions sent to LillyDirect
Pharmacy Solutions would now be delivered by either Amazon
Pharmacy or Truepill, depending on the patient's insurance
coverage and other factors.
Lilly's vice president of managed healthcare services, Frank
Cunningham, said they planned to split the orders between the
two companies. He said Lilly was "very pleased" with the number
of prescriptions it had filled through LillyDirect but declined
to share the number.
A Lilly spokesperson said in an emailed statement that the
website has generated significant interest since the launch and
that the drugmaker "looked forward to continuing to enhance
LillyDirect with additional medicines, partners and service
providers in the near future."
Cunningham said the Indianapolis-based drugmaker was
considering partnering with a retail pharmacy to offer a pick-up
option for LillyDirect customers.
Walgreens CEO Tim Wentworth told Reuters shortly
after LillyDirect was launched that the pharmacy chain could be
"a very natural potential partner for someone like Lilly."
LillyDirect was launched on the back of surging demand last
year for powerful weight-loss drugs including Zepbound and Novo
Nordisk's Wegovy.
The market for obesity drugs is estimated to reach at least
$100 billion by the end of the decade, as consumers flock to the
new treatments that have been shown to reduce weight by as much
as 20%.
Lilly CEO David Ricks told Reuters in January that the
website would ensure that coupons that bring the cost of
Zepbound down to $550 a month were applied, and would also
encourage users to avoid compounded or fake versions of the
medicine.
The website also connects patients to independent telehealth
providers who can complement their current team of doctors or be
an alternative to in-person care for certain conditions, the
company has previously said.